Exelixis, Inc. (EXEL)
45.43
+0.20
(+0.44%)
USD |
NASDAQ |
Jan 15, 11:35
Exelixis Price: 45.43 for Jan. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vanda Pharmaceuticals, Inc. | 7.58 |
| ADMA Biologics, Inc. | 17.96 |
| Aldeyra Therapeutics, Inc. | 4.265 |
| Natera, Inc. | 239.82 |
| Merck & Co., Inc. | 110.10 |
Price Related Metrics
| PE Ratio | 19.13 |
| PS Ratio | 5.681 |
| PEG Ratio | 0.3723 |
| Price to Book Value | 5.637 |
| Price to Free Cash Flow | 16.67 |
| Earnings Yield | 5.23% |
| Market Cap | 12.18B |
| PEGY Ratio | 0.3723 |
| Operating PE Ratio | 15.85 |
| Normalized PE Ratio | 18.73 |